NanJing Pharmaceutical Company Limited
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Nanjing Pharmaceutical Co., Ltd. was established in 1951 and listed on the Shanghai Stock Exchange in 1996. It is the first listed company in China's pharmaceutical circulation industry and has now developed into a cross regional and networked conglomerate. At the end of 2014, the company partnered with the World 500 and leading pharmaceutical business enterprise, United Boots UK (which later merged with Walgreens USA to become a world-class pharmaceutical and healthcare enterprise led by pharmacies, Walgreens Boots United, also known as "WBA"), actively exploring mixed ownership reform (the company currently holds 31.44% of the shares by the state and 13.88% by WBA). The company's main business is pharmaceutical wholesale and retail chain, with around 80 subsidiary enterprises. Its market network covers Jiangsu, Anhui, Fujian, Hubei and other regions, as well as some regions in Yunnan and Sichuan (with a leading market share in the three provinces of Jiangsu, Anhui, and Fujian). In 2019, the sales revenue was nearly 37.2 billion yuan, ranking among the top eight in the industry scale, with a total asset of about 22 billion yuan. The company adheres to focusing on its main business and innovative development, striving to transform into a modern pharmaceutical and health service enterprise. The company is a pioneer in the domestic pharmaceutical service business and has actively adapted to the requirements of national medical reform policies for many years, striving to explore and practice innovative pharmaceutical service management. The company has been awarded the "12th Five Year Plan" Management Innovation Award in the industry, the National Drug Circulation Innovation Demonstration Enterprise, and has been selected as a pilot enterprise for national supply chain innovation and application. The company's retail business consists of two parts: a health pharmacy and a professional pharmacy, with a total of over 510 retail stores. Among them, there are more than 380 socialized health pharmacies (with over 90% of designated medical insurance qualified stores and 6 century old pharmacies), with business terminals distributed in three provinces and eight cities including Jiangsu, Anhui, and Fujian, and nine regional brand chain institutions such as Baixin Pharmacy. Guided by customer health needs, we carry out member management work based on professional pharmaceutical services; Actively explore the multi-mode pharmaceutical retail business of "physical stores+Internet plus+health management", and create the retail brand of "Nanjing Pharmaceutical Health Management"; Develop retail e-commerce, accelerate B2C and O2O online and offline interactions, and build smart retail projects. Professional pharmacies include their own DTP pharmacies, specialized pharmacies on the hospital side, and chain pharmacies. Among them, 8 professional pharmacies have passed the first batch of standard evaluation and certification of the "Retail Pharmacy Operating Characteristic Disease Drug Service Standards" issued by the China Medical and Commercial Association and have been awarded licenses. The company vigorously develops modern logistics, always committed to strengthening the construction of logistics network, investment in logistics infrastructure, innovation in logistics management and service improvement, and application of modern logistics technology. It has 26 logistics centers. The Nanjing Pharmaceutical Central Logistics Center, located in the national Jiangbei New Area of Nanjing, was officially put into use in October 2018, with a construction area of nearly 70000 square meters. The center adopts the intelligent warehousing and scheduling system independently developed by Nanjing Pharmaceutical, as well as the internationally advanced "storage and distribution integration" intelligent shuttle automatic picking system. It is the first in the country to use KIWA robot technology in cold storage, C-class disassembly, and full box picking operations, making logistics operations more efficient More convenient and flexible, it is a leading modern logistics center in the industry in terms of scale, intelligence level, and functional completeness. The company adheres to technological innovation and leadership, strives to create a "digital" Southern Pharmaceutical, and improves the overall operational quality and efficiency of the enterprise. The company has been shortlisted for the demonstration of the pharmaceutical modern supply chain system project in the field of circulation in Nanjing; Promote "Internet plus medical" (Internet hospital), "Internet plus drug consortium" (smart retail) and other "Internet plus" innovation projects; The "Medical Patient Integrated Intelligent Traditional Chinese Medicine and Pharmacy Service" project was awarded the "2018 Smart Jiangsu Key Project"; Collaborated with Nanjing University of Posts and Telecommunications in industry, academia, and research, and the South Pharmaceutical Intelligent Health Engineering Research Center was awarded the title of "Nanjing Engineering Research Center"; The subordinate information technology subsidiary (Jiangsu Zhongjian Zhikang Information Technology Co., Ltd.) is a high-tech enterprise with relevant software copyrights and utility model patents, providing information technology support and guarantee for the implementation of the group's strategy. The company takes "providing health products and services to the public and society, making people's lives healthier, safer, and more dynamic" as its corporate mission, and "becoming a healthy enterprise with social respect, public trust, and employee satisfaction" as its corporate vision. It is a designated unit for emergency reserve of pharmaceutical equipment in Jiangsu, Anhui, Fujian, and other regions, as well as strategic reserve of pharmaceutical equipment in the General Rear of the People's Liberation Army and the Navy. The company actively fulfills its social responsibility and strictly carries out various business management activities in accordance with drug regulatory requirements. Since its listing in 1996, it has achieved nearly 7 billion yuan in profits and taxes; Actively donate and provide relief medicine and equipment in domestic earthquake relief and public health emergencies.As a state-owned holding listed company, Nanjing Pharmaceutical, in the fight against the COVID-19 in 2020, earnestly shouldered the political and social responsibilities of state-owned enterprises, and made every effort to ensure the supply of epidemic prevention and control materials and maintain market order in the main areas covered by its business. The majestic passage is like iron, and now we are stepping from the beginning. Nanjing Pharmaceutical will continue to promote enterprise transformation, innovation, and leapfrog development, focusing on building a technology enabled pharmaceutical smart supply chain, committed to becoming a reliable health product and service provider in the big health industry, rewarding shareholders and society with high-quality development and excellent performance, and striving to make due contributions to public health and the development of the big health industry!. |
| Headquarter | Nanjing |
| Establish Date | 1/25/1994 |
| Listed Code | 600713.SH |
| Listed Date | 7/1/1996 |
| Chairman | Zhou Jianjun. |
| CEO | Zhang Liang. |
| Website | www.njyy.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
